Position in BMRN
as of Mar 31, 2026
· filed Apr 9, 2026
Position Value
$230,705
+$3,179 QoQ
Shares Held
4,084
-2.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Wedmont Private Capital holds $14,119,633 across 15 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
40,281 | $7,543,825 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,524 | $1,750,476 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,310 | $816,837 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,474 | $596,159 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
15,587 | $551,623 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
6,723 | $533,066 | |
| 7 | EXEL |
Exelixis, Inc.
|
8,342 | $453,888 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,413 | $425,355 |
All Filings in BMRN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $230,705 | 4,084 | Shares | Sole | 2026-04-09 | |
| 2025-09-30 | $227,526 | 4,201 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $241,428 | 4,392 | Shares | Sole | 2025-07-10 | |
| 2024-12-31 | $419,094 | 6,376 | Shares | Sole | 2025-01-13 | |
| No filing history on record for this holder in this stock. | ||||||